Connecticut Attorney General William Tong’s office has begun an investigation into health claims made by JUUL Labs Inc., citing the company’s marketing of its products as smoking-cessation devices.
Tong noted that JUUL never received permission from the U.S. Food and Drug Administration (FDA) to market its vaping products as effective tools to help people quit smoking. The investigation will also probe the work of JUUL’s Enterprise Markets Team, which was founded in 2018 with the goal of forming new agreements with health plans, health providers, employers and the public sector.
JUUL, which is partially owned by Altria, the parent company of tobacco giant Philip Morris USA, was given a Sept. 3 deadline for turning over requested documents to Tong’s office.
“JUUL has never been approved as an effective smoking cessation device,” said Tong. “In fact, there is mounting evidence to the contrary. Our investigation will seek to determine whether JUUL is making health claims without FDA approval in violation of the law.”